GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Gabelli Healthcare & WellnessRx Trust (NYSE:GRXpB.PFD) » Definitions » Net Income (Continuing Operations)
中文

Gabelli Healthcare & WellnessRx Trust (Gabelli Healthcare & WellnessRx Trust) Net Income (Continuing Operations)

: $0.42 Mil (TTM As of Dec. 2023)
View and export this data going back to 2014. Start your Free Trial

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Gabelli Healthcare & WellnessRx Trust's Net Income (Continuing Operations) for the six months ended in Dec. 2023 was $-4.38 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.42 Mil.


Gabelli Healthcare & WellnessRx Trust Net Income (Continuing Operations) Historical Data

The historical data trend for Gabelli Healthcare & WellnessRx Trust's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gabelli Healthcare & WellnessRx Trust Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income (Continuing Operations)
Get a 7-Day Free Trial 53.16 24.18 42.74 -47.44 0.42

Gabelli Healthcare & WellnessRx Trust Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.23 -46.71 -0.73 4.80 -4.38

Gabelli Healthcare & WellnessRx Trust Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gabelli Healthcare & WellnessRx Trust  (NYSE:GRXpB.PFD) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.


Gabelli Healthcare & WellnessRx Trust Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Gabelli Healthcare & WellnessRx Trust's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


Gabelli Healthcare & WellnessRx Trust (Gabelli Healthcare & WellnessRx Trust) Business Description

Traded in Other Exchanges
Address
One Corporate Center, Rye, NY, USA, 10580-1422
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least 80% of its assets in equity securities and income-producing securities of domestic & foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.

Gabelli Healthcare & WellnessRx Trust (Gabelli Healthcare & WellnessRx Trust) Headlines